Risk of new-onset heart failure in patients using sitagliptin: a population-based cohort study.

about

Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis.

P2860

Q26785454-F8011E66-728A-4B07-9DF1-8D5A964FF720 Q41176211-ECB460D1-D03D-42BF-8C2B-E11270A31BB7

P2860

Risk of new-onset heart failure in patients using sitagliptin: a population-based cohort study.

Item

http://www.wikidata.org/entity/Q40701673

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Risk of new-onset heart failur ...... population-based cohort study.

@en

type

Item

label

Risk of new-onset heart failur ...... population-based cohort study.

@en

prefLabel

Risk of new-onset heart failur ...... population-based cohort study.

@en

P1476

Risk of new-onset heart failur ...... population-based cohort study

@en

P2093

A Senthilselvan

http://www.w3.org/2001/XMLSchema#string

D L Weir

http://www.w3.org/2001/XMLSchema#string

D T Eurich

http://www.w3.org/2001/XMLSchema#string

S H Simpson

http://www.w3.org/2001/XMLSchema#string

P2860

Part 10: Acute Coronary Syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

An incidence density sampling program for nested case-control analyses

Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Application of the missing-indicator method in matched case-control studies with incomplete data.

Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.

A primer and comparative review of major US mortality databases.

Heart failure: the frequent, forgotten, and often fatal complication of diabetes.

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials.

P304

621-630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DME.12867

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Finlay A McAlister

P577

2015-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280327044

http://www.w3.org/2001/XMLSchema#string

P698

26206341

http://www.w3.org/2001/XMLSchema#string

Risk of new-onset heart failure in patients using sitagliptin: a population-based cohort study.

about

P2860

P2860

Risk of new-onset heart failure in patients using sitagliptin: a population-based cohort study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698